Sorrento Therapeutics Inc (SRNE)
0.02
0.00 (0.00%)
USD |
OTCM |
Apr 24, 15:59
Sorrento Therapeutics Revenue (TTM): 64.27M for June 30, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 64.27M |
| March 31, 2023 | 60.71M |
| December 31, 2022 | 62.84M |
| September 30, 2022 | 60.32M |
| June 30, 2022 | 54.98M |
| March 31, 2022 | 57.03M |
| December 31, 2021 | 52.90M |
| September 30, 2021 | 51.33M |
| June 30, 2021 | 51.02M |
| March 31, 2021 | 46.52M |
| December 31, 2020 | 39.99M |
| September 30, 2020 | 41.52M |
| June 30, 2020 | 35.54M |
| March 31, 2020 | 33.01M |
| December 31, 2019 | 31.43M |
| September 30, 2019 | 25.33M |
| June 30, 2019 | 23.65M |
| March 31, 2019 | 21.09M |
| December 31, 2018 | 21.19M |
| September 30, 2018 | 34.67M |
| June 30, 2018 | 152.48M |
| March 31, 2018 | 153.23M |
| December 31, 2017 | 151.86M |
| September 30, 2017 | 135.47M |
| June 30, 2017 | 15.80M |
| Date | Value |
|---|---|
| March 31, 2017 | 12.04M |
| December 31, 2016 | 8.152M |
| September 30, 2016 | 5.47M |
| June 30, 2016 | 4.33M |
| March 31, 2016 | 4.601M |
| December 31, 2015 | 4.59M |
| September 30, 2015 | 4.051M |
| June 30, 2015 | 4.224M |
| March 31, 2015 | 3.826M |
| December 31, 2014 | 3.825M |
| September 30, 2014 | 3.128M |
| June 30, 2014 | 1.935M |
| March 31, 2014 | 1.302M |
| December 31, 2013 | 0.46M |
| September 30, 2013 | 0.4812M |
| June 30, 2013 | 0.5327M |
| March 31, 2013 | 0.6079M |
| December 31, 2012 | 0.584M |
| September 30, 2012 | 0.5897M |
| June 30, 2012 | 0.5469M |
| March 31, 2012 | 0.404M |
| December 31, 2011 | 0.5292M |
| September 30, 2011 | 0.913M |
| June 30, 2011 | 0.9356M |
| March 31, 2011 | 0.9179M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
23.65M
Minimum
Jun 2019
64.27M
Maximum
Jun 2023
46.61M
Average
51.02M
Median
Jun 2021
Revenue (TTM) Benchmarks
| Scilex Holding Co | 46.74M |
| AIM ImmunoTech Inc | 0.202M |
| Perspective Therapeutics Inc | 0.00 |
| Protalix BioTherapeutics Inc | 65.49M |
| Armata Pharmaceuticals Inc | -- |